Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, today announced that its diagnostic imaging technology for women’s health ‘Crystal Vue’ is featured on the cover of the American Journal of Obstetrics & Gynecology (AJOG) in the July edition.

Crystal Vue, one of the flagship features of Samsung’s premium WS80A ultrasound system, is an advanced 3D volume rendering technology that enables users to assess detailed information of internal and external structures of the fetus or uterus.

“Samsung’s ultrasound technology continues to be recognized by leading academic journals around the world,” said Insuk Song, Vice President of the Health & Medical Equipment of Samsung Electronics. “Along with Crystal Vue and other innovative features such as Crystal Vue Flow, E-Cervix, 5D Heart Color, IOTA-ADNEX, we are focusing on offering clinical value as the industry‘s leading diagnostic solution provider.”

AJOG selected a clinical case* by Sa Ra Lee, MD, PhD in the Department of Obstetrics and Gynecology, Ewha Womans University College of Medicine in Korea, and included a clinical image of transvaginal ultrasonography obtained by Samsung’s Crystal Vue. The 3D image clearly visualizes the internal and external contours of the urinary bladder and dilated distal ureter obstructed with a ureteral stone at the ureterovesical junction.

“Transvaginal pelvic ultrasonography provides clear images of the pelvic organs, helping the evaluation of women with gynecological symptoms,” said Sa Ra Lee in her study. “The use of three-dimensional reconstructed images by adding the recently developed post-rendering techniques can provide additional information in the evaluation of the lower urinary system.”

The function was also showcased in the May issue of AJOG in a case of cesarean scar pregnancy by Sa Ra Lee, as well as featuring on the cover of Ultrasound in Obstetrics & Gynecology (UOG) as the picture of the month in both the March 2016 and April 2017 editions of the publication. With WS80A’s installments in the world, Samsung is actively enhancing its brand with the technology’s clinical usability.

For more information on Samsung’s global medical equipment business, please visit, www.samsunghealthcare.com.

*This article was published in the American Journal of Obstetrics & Gynecology, Vol. 217, Sa Ra Lee, MD, PhD; Ha Na Yoon, MD, PhD, Ureteral stone diagnosed with 3-dimensional transvaginal ultrasonography, Page No. 88.e1~e2, Copyright Elsevier (2017).

“At this congress, Samsung is introducing a comprehensive diagnostic solution for women from family-planning to cancer screening, helping accurate diagnosis for health issues that women may experience throughout their lifetime,” said Dongsoo Jun, President of Health & Medical Equipment Business of Samsung Electronics and CEO of Samsung Medison. “Samsung is committed to creating solutions that provide clinicians with better imaging and help them make better management decisions for their patients. We see our collaboration with the International Society of Ultrasound in Obstetrics and Gynecology as integral to this.”

The key highlights at the congress include:

Total Solution for Women’s Health

• Crystal Clear — Defining women’s lifetime diagnostic challenges into four repetitive categories from family-planning, healthy pregnancy, healthy birth to Gynecology & breast health, Crystal Clear is Samsung’s comprehensive ultrasound imaging solution that provides continuous diagnostic tools designed for each stage. With one Samsung ultrasound system, clinicians can provide proper diagnosis to any Obstetrics and Gynecology patients.

Combining Intelligence and Imaging by Incorporating Decision Support Tool

• IOTA-ADNEX — In collaboration with the International Ovarian Tumor Analysis (IOTA) group, Samsung has incorporated the ADNEX (Assessment of Different NEoplasias in the adneXa) decision support tool for the classification of ovarian tumors into the ultrasound system. The ADNEX model not only accurately classifies ovarian masses as benign or malignant, but also sub-classifies malignancies giving the opportunity for more nuanced management decisions. Once the straightforward ultrasound variables have been entered into the model, ADNEX automatically gives a graphical representation of the risks of ovarian cancer to the clinician, enabling instant feedback to the patient.

At the Samsung IOTA Symposium on the 25th, Prof. Tom Bourne, from Imperial College London and a member of the steering committee of the IOTA group said, “The ADNEX model is based on data from over 5,900 women from 24 centers in ten different countries. It is a decision support tool that has both a high sensitivity and specificity for ovarian cancer, but can also sub-classify malignancies to help personalize management for patients. Integrating the model into the ultrasound machine makes it easy to use and in effect builds intelligence into the machine.”

Advanced Visualization of Fetus Anatomy

• Crystal Vue Flow — Samsung also introduced new Crystal Vue Flow, by adopting Crystal Vue which is an advanced 3D volume rendering technology and featured on the front cover of the Ultrasound in Obstetrics & Gynecology (UOG) journal in March 2016. In addition to innovative volume rendering technology, it now adds flow information that shows vascular structures with increased depth perception and demonstrates vessels in different imaging planes.

Prof. Christoph Lees, visiting Professor at KU Leuven, Belgium and Reader in Obstetrics and Fetal Medicine at Imperial College in the U.K., said, “For visualization of fetus, evaluation of fetal face and CNS, we found that Crystal Vue may provide more anatomical information the conventional 2D or 3D ultrasound can give imaging comparable to MRI,” adding, “Crystal Vue Flow combines morphological information with hemodynamic flow, and allows a deeper understanding of fetal vascular anatomical variants and neighboring vessels, particularly valuable in our experience for morbidly adherent placenta.”

With a complete package of women’s health diagnostic tools including IOTA-ADNEX and Crystal Vue Flow, Samsung will launch the WS80A with Elite containing these features from later this year.

For more information on Samsung’s global medical equipment business, please visit, www.samsungmedicalsolution.com

Samsung’s WS80A with Crystal Vue technology.

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, announced that its latest imaging technology ‘Crystal Vue’ has been featured on the front cover of Ultrasound in Obstetrics & Gynecology (UOG), a renowned academic journal in the women’s healthcare industry and the official journal published by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).

The March edition of the UOG featured a clinical case study by Dr. Christoph Lees, professor at the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in London. Using Samsung’s premium diagnostic ultrasound system WS80A, professor Lees introduced two cases of prenatal imaging through Crystal Vue, of which the rib & vertebral images were selected as the Picture of the Month by UOG.

“Our experience with Crystal Vue over the past few months, specifically imaging of the bone and soft tissue interface, leads us to believe that it may offer new opportunities for prenatal imaging, particularly for the skeletal system, but also in facial and brain imaging,” Professor Lees stated in his study. “We were able to obtain highly detailed images that give particular information on the contour of the ribs and allow inference on mineralization.”

Crystal Vue is an advanced 3D volume rendering technology that enables users to assess detailed information of internal and external structures of the fetus or uterus and helps easily differentiate between the soft tissue and bone. With the additional morphological information, users may deepen their understanding of the patients and fetus.

Crystal Vue was first introduced at the 25th World Congress on Ultrasound in Obstetrics and Gynecology, held in Canada in October 2015, as the latest imaging function of the WS80A. The WS80A with Crystal Vue is currently available globally.

“We are thrilled that Samsung’s latest technology was recognized in a leading academic journal as a new diagnostic imaging that can provide more clinical values in women’s health,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “With Samsung’s leading display and software technology, we will continue to develop new features that can increase diagnosis confidence and contribute to women and fetal health.”

The cover of the March issue of Ultrasound in Obstetrics & Gynecology.

To access the case study featured in the UOG, please visit,

http://onlinelibrary.wiley.com/doi/10.1002/uog.15800/full.

For detailed information on the Crystal Vue and WS80A, please visit,

http://www.samsungmedison.com/micro/WS80A_with_Elite/main.jsp.

To learn more about Samsung’s global medical equipment business, please visit,

http://www.samsung.com/global/business/healthcare/.